Table 2.
Main characteristics of the estimators based on molecular and genetic markers.
Reference | Methodology | Accuracy Reported | Sample Types | Number of Samples (Overall) | Age Range (Years) | Comments | Associations with Age-Related Conditions and Diseases |
---|---|---|---|---|---|---|---|
Fleischer J. et al. [30] | Linear regression10-fold cross-validation | MAE = 7.7 years MAE (median) = 4 years |
Human dermal fibroblasts | 133 (people) 10 Hutchinson-Gilford progeria syndrome patients |
1–94 2–9 |
Predicts progeria patients as 15–24 years older than age-matched controls; hence, provides an accurate estimation of biological age The only method that predicts accelerated aging in HGPS patients |
No associations reported |
Van den Akker E. et al. [41] | Linear regression 5-Fold-cross-validation |
R2 = 0.65 MAE = 7.3 years |
Blood metabolome | 25,000 | - | Only a biological sample required; no additional metadata needed Participants with current metabolic syndrome or diabetes mellitus type 2 were estimated older than healthy counterparts |
Cardiometabolic health; increased risk of hospitalization due to heart failure, cognitive decline and cardiovascular and all-cause mortality; in nonagenarians, lower instrumental activities of daily living and increased risk of all-cause mortality during 10 years of follow-up |
Ren X. et al. [32] | Elastic net | Multiple | Multiple | 9662 | - | Transcriptional age is significantly impacted by race The first model to perform RNA-Seq-based identification of differential gene expression for each individual tissue type |
Significant correlation between the transcriptional age acceleration and mutation burden, mortality risk, and cancer stage in several types of cancer; Complementary information to DNA methylation age |
Meyer D. et al. [33] | Temporal scaling and binarization | R2 = 0.92 MAE = 6.63 years MAD = 5.24 |
Blood | 1020 | - | Universal applicability, no methylation analysis required; Improved accuracy for HGPS patients compared with Fleischer’s transcriptome-based model; no DNA methylation in C. elegans, hence the effect of the epigenetic clocks in gene expression is unclear. |
No associations reported |
Wang J. et al. [35] | Multivariate linear regression (MLR) Regression tree (best performing) Bagging regressionRandom forest regression (RFR, best performing) Support vector regression (SVR) |
MAE = 8.767 years (S.rho = 0.6983) MAE = 9.126 years (S.rho = 0.660) |
Blood | 100 | 19–73 | Significantly smaller prediction MAE values for males than females (MAE = 6.133 years for males and 10.923 years for females in the regression tree model) | No associations reported |
Peters M. et al. [29] | Meta-analysis | Multiple | Blood | 14,983 (individuals) | - | Lower predictive accuracy compared to epigenetic clocks | Higher systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, fasting glucose levels and body mass index (BMI) |
Zubakov D. et al. [42] | Linear regression with sjTREC as a single predictor | R2 = 0.835, p = 8.16 × 10−215 Standard error of the estimate ± 8.9 years; |
Blood | 195 (individuals) | 0–80 | Storage time analysis showed no statistically significant difference between the sjTREC quantifications in fresh and 1.5-year-old blood samples of the same individuals | No associations reported |
Galkin F. et al. [43] | Elastic Net (EN) Random Forest (RF) Gradient Boosting (XGB) Deep Neural Networks (DNNs) |
MAE = 5.91 years | Stool | 4000 | 18–90 | Accuracy comparable to the existing DNAm solutions (MAE < 5 years) The microbiome composition (such as Akkermansia muciniphila, a marker of obesity, glucose metabolism, and overall intestinal health) could be used in diagnosing gut metabolism disorders; further research needed due to inconsistent results |
No associations reported |
Lahallier B. et al. [40] | SomaScan assay | Multiple | Plasma | 2925 | 18–95 | At peaks 2 and 3 (at the ages of 60 and 78), the proteins were associated with cardiovascular diseases, as well as Alzheimer’s disease and Down syndrome |